Specifically, loss of p53 appears to cooperate with oncogenic K-ras-induced pancreatic cancer initiation and progression, by perturbing cell cycle progression, impairing DNA damage repair, augmenting survival activities and hindering apoptosis in cells [35, 36]. The gene discussed is KRAS; the disease is pancreatic neoplasm.